Executive Commentary

James Whittenburg, president and chief executive officer, commented, “The broad spectrum of products and services HealthTronics offers urologists continues to be our strength — contributing to our financial results as well as the leadership position we enjoy within the urology field. Furthermore, the scope and size of our channel in urology equips us with extensive knowledge concerning emerging trends, new treatment alternatives, and evolving applications for existing technology. With this knowledge, we can continue to play a critical role in expanding treatment alternatives for patients and physicians alike, bringing leading-edge equipment and support services for the screening, diagnosis and treatment of diseases.”

Whittenburg continued, “During the second and third quarter, we intend to continue our revenue growth as well as reduce operating expenses by approximately $1.0 million, principally in the form of workforce reductions and relocations from acquisitions made during 2008. This expense reduction, combined with ongoing investments in our core businesses, will help improve HealthTronics’ financial performance.”